mploys heat to disable pain-transmitting nerves and is used to treat various chronic pain syndromes. The company’s primary Neuromodulation Products' competitors include Medtronic, Boston Scientific, Nevro Corp., and Stryker Corporation. Thoratec Products Thoratec Products include ventricular assist devices and percutaneous heart pumps, both of which facilitate blood flow from the chambers of the heart throughout the entire body. Primarily, ventricular assist devices provide mechanical circulatory support for the treatment of heart failure patients by supplementing the pumping function of the heart. Percutaneous heart pumps continuously generate average blood flow through a percutaneous insertion during complex revascularization procedures. The company’s primary Thoratec Products' competitors include AbioMed, Inc. and HeartWare International, Inc. Marketing and Distribution The company’s products are sold in approximately 100 countries throughout the world. In the United States and Canada, the company sells directly to healthcare providers primarily through a direct sales force. In Europe, the company has direct sales organizations in 21 different countries, selling throughout Europe, the Middle East and Africa. In Japan, the company sells directly to healthcare providers through a direct sales force, and the company continues to use longstanding independent distributor relationships. In the Asia Pacific, the company has direct sales organizations in 10 different countries. In Latin America, the company has direct sales organizations in five different countries. Some of its direct sales in the Asia Pacific and Latin America also include sales to independent distributors. Throughout the rest of the world, the company uses a combination of direct sales forces and independent distributors. Government Regulation The development, manufacturing and marketing of the company’s products is subject to regulation by government agencies, both within and outside the United States, including but not limited to, the Food and Drug Administration and the relevant authorities in the member states of the European Union. Seasonality The company’s quarterly net sales are influenced by many factors, including new product introductions, acquisitions, regulatory approvals, patient and physician holiday schedules and other factors. Net sales in the third quarter (year ended January 2016) are typically lower than other quarters of the year as a result of patient tendencies to defer, if possible, procedures during the summer months and from the seasonality of the U.S. and European markets, where summer vacation schedules normally result in fewer procedures. Research and Development The company’s research and development expenses were $676 million in 2015. History St. Jude Medical, Inc. was founded in 1976. The company was incorporated in Minnesota in 1976.
st jude medical inc (STJ:New York)
One St. Jude Medical Drive
St. Paul, MN 55117
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for STJ.|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ST JUDE MEDICAL INC, please visit www.sjm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.